Saturday 17 October 2026
Export SER’s income statement to Excel — free account
Serina Therapeutics, Inc.
In the quarter to June 2026, revenue grew 2,500.0%, EPS grew 16.7% and free cash flow fell 76.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.77
0.02
−1.12%
Follow SER
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.98 | 0.86 | 3.87 | 6.12 | |
Current Ratio |
1.31 | 1.71 | 4.18 | 6.65 | |
Net Debt/EBITDA |
0.90 | 0.02 | 3.47 | 2.98 | |
Debt/Assets |
23.27% | 42.38% | 11.03% | 11.96% | |
Debt/Equity |
1.81 | (79.62) | 0.17 | 0.16 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | 1.87 | 0.66 | 0.75 | |
Capex/Depreciation |
(0.81) | 0.00 | (0.30) | (0.29) | |
Interest Coverage |
(1,065.33) | (31.35) | (33.23) | (33.42) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.37) | (0.59) | (0.38) | (0.41) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.37) | (0.59) | (0.38) | (0.41) | |
Cash per Share |
0.83 | 0.30 | 2.04 | 1.41 | |
Shareholders Equity per Share |
0.15 | 0.00 | 1.46 | 1.14 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.15 | 0.00 | 1.46 | 1.14 | |
Free Cash Flow |
(3.86) | (6.03) | (4.59) | (6.71) | |
Working Capital |
2.71 | 2.52 | 20.13 | 21.27 | |
Capital Expenditures |
(0.01) | 0.00 | (0.02) | (0.03) | |
Net Current Asset Value |
0.68 | (0.91) | 16.80 | 17.95 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
2.21 | 1.34 | 2.01 | 1.78 | |
Average Assets |
9.92 | 6.84 | 17.02 | 17.38 | |
Average Common Equity |
(8.59) | (2.23) | 7.12 | 7.72 |
Columns are period end dates